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ABSTRACT
Aim: The purpose of this study is to observe the volume change of prostate and laser-ablated lesions
in the canine and to explore the mechanism and clinical significance through histopathology.
Materials and methods: Transperineal laser ablation (TPLA) was performed under the guidance of
transrectal ultrasound (TRUS) in eight canines. Two canines were sacrificed 1 day and 1 week after
TPLA, respectively. The remaining six canines were sacrificed after finishing transrectal contrast-
enhanced ultrasound (TR-CEUS) at three phases.
Results: The prostatic volumes immediately following TPLA and 1 week later were larger than before
TPLA (20.1±3.9 vs 17.1 ±3.8ml; 21.7 ± 3.6 vs 17.1 ± 3.8ml, p< 0.05), but 1 month later, returned to the
preoperative level (17.4 ± 3.2ml). At three time points, the mean volumes of laser-ablated lesions at
3W/600 J were 0.6±0.2, 1.1 ± 0.4, and 1.7 ±0.5ml, respectively, while those of laser-ablated lesions at
3W/1200 J were 1.2 ± 0.2, 1.6 ± 0.3, and 2.2±0.5ml, respectively. The mean volumes of laser-ablated
lesions increased significantly over time after TPLA (p< 0.050).
Conclusion: The prostate volume transient enlarges after TPLA, which prompts for clinical application
that it should prolong appropriately the duration of urinary catheterization to avoid acute urinary
retention. Many inflammatory cells were observed in the laser-ablated lesions and adjacent normal
prostate parenchyma through histopathology. It is speculated that the inflammatory response is
involved in the progression of tissue damage.
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Prostate cancer (PCa) is the most commonly diagnosed solid
cancer among men, and remains a leading cause of cancer
death [1]. For the low risk and localized PCa, focal therapy
could reduce the complication of radical prostatectomy,
including incontinence, impotence, and damage to surround-
ing organs [2]. Focal therapy aims to maintain the onco-
logical benefit of active treatment options and reduces the
risk of side effects through preserving noncancerous tissues,
which possesses advantages of minimally invasiveness, local
anesthesia, shorter length of stay in hospital, and fast recov-
ery [3]. Focal therapy of the prostate could be administered
by several modalities: high-intensity focused ultrasound
(HIFU) [4], cryoablation [5], photodynamic therapy [6], laser
ablation [7], radiofrequency ablation (RFA) [8], and micro-
wave ablation (MWA) [9].
Percutaneous laser ablation is performed by delivering the
laser light inside the tissue usually via a flexible optical fiber
with a small diameter (0.20.8mm). The light absorbed by
the tissue is converted into heat, and the short-interval
exposure of tissue cells to a temperature of higher than
60 C causes irreversible damages [10,11]. The percutaneous
laser ablation could create accurate, predictable, and repro-
ducible ablation zones and induce minimal changes to the
tissues outside the targeted ablation zone. Prostate tissue is
particularly well suited for laser ablation due to its optical
absorption rate and lack of excessive vascularity [12]. The
laser ablation for moderate-risk PCa was found safe and feas-
ible in phases I and II clinical trial [7,13].
Previous literature reported that the application of laser in
benign prostate hyperplasia (BPH) mostly focused on the
transurethral approach [14], which may result in retrograde
ejaculation and complications, such as hematuria and urinary
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retention, while urethral and bladder neck strictures still
occur. Transperineal laser ablation (TPLA) is a novel option
for minimally invasive treatment of benign prostatic obstruc-
tion [15,16]. TPLA could be performed under local anesthesia.
Besides, the transperineal approach avoids damage to the
urethral channel. Approximately 50% of men over 50 years of
age will show pathological evidence of BPH, and this number
increases to 80% in men with an age of more than 80 years
old [17]. BPH is a common cause of lower urinary tract
obstruction in men, which reduces the quality of life [18].
The symptoms of lower urinary tract obstruction in patients
who underwent TPLA were significantly relieved at 3 and 6
months [19]. However, previous studies have reported that
the laser-ablated volume in liver tumors has increased imme-
diately after the laser ablation operation [20,21]. Little is
known about the volume change of prostate and laser-
ablated lesions in a short time after TPLA. The transient
enlargement of prostate volume will result in acute urinary
retention. The catheterization time for patient underwent
prostatic focal therapy varied from 1 to 15 days [19,22].
In this study, it was attempted to observe the dynamic
volume change of prostate gland and laser-ablated lesions in
canine treated by TPLA and provide valuable information for
determining the duration of urinary catheterization and the
evaluation time of laser-ablated lesions after TPLA. The vol-
ume can be evaluated by transrectal contrast-enhanced ultra-
sound (TR-CEUS), which had been verified to assess
hyperthermal lesion volume in the prostate [23,24].
Materials and methods
Animals
The study protocol was approved by the Ethics Committee
of the Center for Drug Safety Evaluation of Zhengzhou
University (Zhengzhou, China). Eight adult male beagles with
a mating history were purchased from Xi’an Dilepu
Biomedical Co., Ltd (Xian, China). The mean age of the bea-
gles was 6.5 ± 0.35 years, and their mean weight was
16.4 ± 2.05 kg. The beagles were kept in the animal center for
the Drug Safety Evaluation of Zhengzhou University
(Zhengzhou, China). All surgical procedures and experiments
were performed under anesthesia, and every effort was
made to minimize animal suffering.
Equipment
An ultrasound system equipped with a transrectal dual-plane
probe (E14CL4b) and contrasted tuned imaging mode (CnTI)
(BK3000; B-K Medical Systems, Inc., Peabody, MA) was used
in this study. The frequency of the probe was 4–14MHz, and
the mechanical index was adjusted to 0.06 in the contrast
imaging mode.
The Echolaser X4 (Esaote SpA, Genoa, Italy) with an Nd:
YAG laser emission source (at a wavelength of 1064 nm) was
used for TPLA. The optical laser fiber with a diameter of
300lm and a length of 20 cm was inserted through the
sheath of the guidance needles, and the tip of the laser fiber
was in direct contact with the tissue.
Preoperative preparation
The animals were fasted for 12 h before the experiment.
Their perineal region was prepared, and a clean enema was
performed using glycerin (Hubei Ketian pharmaceutical co.
LTD, Hubei, China). An indwelling needle was inserted into
the forearm vein for saline infusion.
Anesthesia was induced by the intramuscular injection of
dexmedetomidine (8mg/kg) and Zoletil 50 (2mg/kg). After
5min, propofol (3mg/kg) was injected intravenously. The
beagle was then endotracheally intubated and connected to
a respirator (Ruiwode life technology co. LTD, Shenzhen,
China). Anesthesia was maintained with 2–3% aerosolized
sevoflurane (Shanghai Hengrui Pharmaceutical Co., Ltd,
Shanghai, China) in oxygen during the procedure. All beagles
were placed in a supine position and the body temperature
was maintained with a warmed blanket. An animal-specific
urinary catheter was placed into the bladder of each beagle.
The disinfection and draping of the local perineal area were
then performed.
Ablation experiment
TPLA was performed by a physician with over 5 years of
ablation experience. Under the transrectal ultrasound (TRUS)
guidance, a 21-Gauge guidance needle was first inserted into
each lobe of the prostate via the transperineal approach. The
optical laser fiber was placed through the guidance needle,
and 10mm of the nude fiber tip was exposed to achieve dir-
ect contact with the prostate gland tissue before the fiber
was connected to a continuous-wave emission source. The
distance from the tip of the laser fiber to the outer wall of
the urethra, the rectum, and the bladder wall was more than
6mm, while the distance from the tip of the laser fiber to
the bladder floor was more than 15mm (Figure 1). The abla-
tion process was continually monitored by TRUS. Each treat-
ment was performed with a fixed power (3W), and the total
delivered energy was 600 joule (J) and 1200 J in the left and
right prostate lobes, respectively. Therefore, the ablation
time was determined by the fixed power and the total out-
put energy. The TPLA was performed in eight adult beagles
resulting in sixteen laser-ablated lesions. Two beagles were
sacrificed to observe the pathological information 1 day after
TPLA and 1 week later, respectively. Twelve laser-ablated
lesions in remaining six beagles were used to observe the
dynamic volume change immediately, 1 week and 1 month
after TPLA. Therefore, there were six samples available for
comparison volume at different periods in each group,
including prostate gland and laser-ablated lesions group
(3W/600J and 3W/1200J).
Transrectal contrast-enhanced ultrasound (TR-CEUS)
examinations were conducted to image the prostate and
laser-ablated lesions at about 10min after TPLA. The details
of TR-CEUS examinations were described in the previous art-
icle [25]. Briefly, the machine was adjusted to the contrast
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mode with low mechanical index (0.06). A bolus injection of
0.06ml/kg of SonoVue (Bracco Group, Milan, Italy) was car-
ried out through the indwelling catheter at the forearm vein,
and 5ml of normal saline was used to flush the catheter. TR-
CEUS examinations were repeated 1 week and 1 month
after TPLA.
The range of laser-ablated lesions was bounded by no
enhancement area on the TR-CEUS images. Three biggest
dimensions (a, b, c) of each prostate and laser-ablated lesion
were measured on the TR-CEUS images, respectively. The vol-
ume (V) of the prostate gland and laser-ablated lesions were
calculated according to the formula: V¼ 1/6  p  ab c.
During the TPLA procedure and recovery from anesthesia,
the heart rate, breathing, and body temperature of the ani-
mals were closely monitored. The beagles were fed regularly
after 6 h of monitoring. Each beagle was intramuscularly
administered with 80mg/kg of gentamicin (Sinopharm
Chemical Reagent Co., Ltd., Shanghai, China) once a day in
the morning for 1 week following TPLA to avoid infection.
The signs of hematuria and haematochezia were closely
monitored. Two beagles were sacrificed 1 day and 1 week
after TPLA, respectively, and the remaining six beagles were
sacrificed 1 month after TPLA by using an intravenous injec-
tion of sodium pentobarbital (30mg/kg).
Histopathological examination
Necropsy and gross pathological inspections were performed
immediately after each beagle was sacrificed. The prostate gland
and its surrounding structures (bladder, seminal vesicle gland,
and rectum) were carefully inspected. The prostate was
removed and fixed in the 10% buffered formaldehyde solution
for 24h. The prostate glands of the first two beagles were sliced
in the sagittal section along the laser fiber path. However, the
prostate glands of the six remaining beagles were sliced in the
transverse section at 5mm intervals perpendicular to the
urethra. Then, the sliced specimens were paraffin-embedded,
and 5-lm-thick sections were prepared and stained with
hematoxylin-eosin (HE) for later optical microscopic evaluation,
including necrosis, hemorrhage, and hyperemia.
All histopathological specimens were evaluated by two
experienced pathologists. In addition, the liquid in all the
laser-ablated lesions was aspirated and examined by HE stain-
ing, bacterial culturing (Becton, Dickinson and Company,
America), and complete blood counting. The quantity of white
blood cell, polykaryocyte, and monocyte in the cystic fluid
was analyzed using automatic blood cell analyzer (Shanghai
Xiesen Meikang Medical Electronics Co. Ltd, China).
Statistical analysis
The SPSS 22.0 software (IBM, Armonk, NY) was used to per-
form the statistical analysis. Quantitative data were expressed
as mean± standard deviations (M± SDs). The comparison of
volumes of prostate and laser-ablated lesions at different
time points was done using paired t-tests. p< 0.050 was con-
sidered statistically significant.
Results
TPLA procedures in all beagles were performed successfully
with no major complications. No signs of hematuria, haema-
tiochezia, and infection were found during the 1-month fol-
low-up.
Characterization of laser-ablated lesions on TRUS and
TR-CEUS
Real-time TRUS can be used to visualize needle insertion and
guide laser fiber deployment. The laser-ablated lesions
appeared as gradually expanded hyperechoic areas located
in front of the laser fiber tip during the ablation progress.
Immediately after TPLA, the shape of the laser-ablated lesion
was irregular without a clear boundary (Figure 2(B)).
However, 1 week and 1 month after TPLA, the laser-ablated
lesions become hypoechoic areas with relatively clear
Figure 1. The position and orientation of the laser applicator on transrectal ultrasound images (A, transverse section; B, longitudinal section). The distances from
the tip of the laser applicator to prostatic capsule (a, d), the outer wall of the urethra (b), the rectum wall (e), and the bladder floor (c).
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margins, which may be contributed by the formation of
lesion cyst (Figure 2(C,D)).
After TPLA, each laser-ablated lesion was observed as an
avascular defect area within the normal perfused gland on
TR-CEUS image. The shape of laser-ablated lesions was round
on the transverse and elliptic on the longitudinal section
images, so the shape of it was ellipsoidal on the whole,
which has been described in the previous study [25]. The fol-
low-up TR-CEUS examination carried out 1 week and 1
month after TPLA displayed the laser-ablated lesions with a
demarcated boundary (Figure 2(b–d)).
Dynamic volume changes of the prostate gland and
laser-ablated lesions over time
The volumes of prostate glands and laser-ablated lesions
were measured by TRUS and TR-CEUS in the remaining six
beagles, respectively. Before TPLA, the mean volume of pros-
tate glands was 17.1 ± 3.8ml. The mean volumes of prostate
glands were 20.1 ± 3.9ml and 21.7 ± 3.6ml immediately and
1 week after TPLA, respectively, which were significantly
larger than the baseline value (p< 0.050). The volume of the
prostate returned to the baseline level (17.4 ± 3.2ml) 1
month after TPLA (Table 1).
At the three time points, the mean volumes of the laser-
ablated lesions at 3W/600J were 0.6±0.2, 1.1±0.4, and
1.7±0.50ml, respectively, while the mean volumes of lesions at
3W/1200J were 1.2±0.2, 1.6±0.3, and 2.2±0.5ml, respectively.
The volumes of all laser-ablated lesions increased significantly
over time within 1 month after TPLA (p< 0.050) (Table 1).
Histopathological evaluation of laser-ablated lesions in
canine prostate
Regarding the first beagle sacrificed 1 day after TPLA, the
gross inspection revealed that the urethra, the rectum, and
the seminal vesicle appeared normal in situ, and the prostate
capsule showed bleeding bands indicating acute hyperemia.
The laser-ablated thermal lesion within the prostate
appeared as an oval-shaped dark brown area in the center
surrounded by a yellowish band (Figure 3(A)). The laser-
ablated lesions were shown in three zones: the coagulative
zone (CZ), marginal transition zone (MZ), and untreated zone
(UZ), in the direction from the lesion center (Figure 3(B)) to
the peripheral normal prostate tissue in the images of HE
staining observed under the microscope (Figure 3(B)).
The gross inspection of the beagle sacrificed 1 week after
TPLA showed findings similar to those of the first beagle.
However, a small amount of fluid was seen in the center of
the laser-ablated lesion. The microscopic images of the HE
staining of the specimens showed the three zones of lesions.
The inner layer of MZ close to CZ showed a bleeding band,
while the out layer of MZ close to UZ was infiltrated with
inflammatory cells, including neutrophils, macrophages, and
lymphocytes (Figure 4).
Regarding the remaining six beagles scarified 1 month
later, the gross specimens of the prostate appeared plump-
ness. All laser-ablated lesions eventually developed into
liquefaction cavity. The liquid was yellow-brown and viscous
(Figure 5(A1)). Many inflammatory cells were found in the
liquid on the HE staining images, including neutrophils, lym-
phocytes, and macrophages (Figure 5). No bacterial growth
was seen in the fluid after 72 h of culturing. There were
many inflammatory cells infiltrated through the cavity wall
and the normal prostate tissue (Figure 5(C1, 5C2)). The quan-
tity of white blood cell, polykaryocyte, and monocyte in the
cystic fluid were 50.1 ± 54.9 109/L, 7.8 ± 1.3 109/L, and
1.5 ± 0.9 109/L, respectively.
Discussion
The TPLA operation the prostate in all beagles was guided
by TRUS and was performed successfully. There were no
signs of hematuria and haematochezia in these beagles
Figure 2. The prostate gland and laser-ablated lesions in beagles prostate were evaluated by TRUS Images (A, B, C, D) and TR-CEUS images (a, b, c, d) before and
after TPLA. TPLA: transperineal laser ablation.
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during the 1-month follow-up. Besides, the organs adjacent
to the prostate appeared normal.
In this study, real-time TRUS was able to precisely guide
the laser fiber placement and monitor the entire ablation
procedure, which was consistent with the previous report
[26]. The prostate gland was clearly observed and could be
precisely evaluated through the TRUS. However, the region
of the laser-ablated lesion appeared as a hyperechoic area
without a regular shape or a clear boundary in the TRUS dur-
ing the process of TPLA. One week and 1 month later, the
laser-ablated lesions were demarcated from surrounding
normal tissue and were observed as low echo region in the
follow-up TRUS examination, which may be contributed by
the formation of lesion cyst. Previous studies have shown
that the TR-CEUS imaging can be used to accurately evaluate
the size of the radiofrequency ablated lesion in the prostate,
which was consistent with pathological results [27]. The
microbubble-based contrast agent could enhance the con-
trast of normal viable prostate tissues but could not enter
the ablated coagulated or necrosis tissues [28]. In this experi-
ment, the peripheral blood vessels of prostate, prostatic cap-
sule, and prostatic parenchyma enhanced gradually in
Table 1. Volumes of the prostate gland and laser-ablated lesions before and after TPLA in beagles.
Volume Number of sample Before TPLA On the day TPLA P One week after TPLA P One month after TPLA P
Prostate (ml) 6 17.1 ± 3.8 20.1 ± 3.9 0.000 21.7 ± 3.6 0.000 17.4 ± 3.2 0.643
Ablated lesion (3W/600J) (ml) 6 — 0.6 ± 0.2 — 1.1 ± 0.4 0.002a 1.7 ± 0.5 0.000b
Ablated lesion (3W/1200J) (ml) 6 — 1.2 ± 0.2 — 1.6 ± 0.3 0.002a 2.2 ± 0.5 0.000b
TPLA: transperineal laser ablation.
aThe volume at 1 week after TPLA compared with that on the day of TPLA.
bThe volume at 1 month after TPLA compare with that on the day of TPLA.
Figure 3. The pathological images of beagle prostate were captured 1 day after TPLA (3W/600J). (A) A photo of the formalin-fixed specimen showing a coagu-
lated/necrotic lesion. (B) A microscopic photo of the prostate with HE staining demonstrating three zones of the laser-ablated lesion, i.e. the coagulative zone (CZ),
the marginal zone (MZ), and the untreated normal zone (UZ), under low magnification (10 ). Note that B1 and B2 are photos of CZ and MZ observed under high
magnification (200 ). TPLA: transperineal laser ablation.
Figure 4. The microscopic images of HE staining of beagle prostate one week after TPLA (3W/600J). (A) A low magnification (10 ) view of the prostate showed
three zones (CZ, MZ, UZ) of the ablated lesion. A1–A4: A high magnification (200 ) view from A demonstrated the structure of each zone in details. CZ: coagula-
tive zone; MZ: marginal zone; TPLA: transperineal laser ablation; UZ: untreated zone.
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sequence after ten seconds injection of the SonoVue, and
the intensity peaked around thirty seconds. At the same
time, the laser-ablated lesions were observed as an avascular
defect area around with enhanced rims in the normal per-
fused gland. The enhanced rims may be the hyperemia zone
according to our histopathology results and previous litera-
tures [21]. The shape of laser-ablated lesions was ellipsoidal,
which has been described in previous study [25]. In addition,
the TPLA needle channel was bright in TR-CEUS, which was
the same echo as the prostatic capsule in the two-dimen-
sional ultrasonography and was verified as the carbonized
tissue through the histopathology, so this “enhanced” was
false appearance. This result reminds that the bright needle
channel was not really enhanced and there was no survival
tissue in clinical application. Some low and high echo tissue
was observed in transrectal two-dimensional ultrasonography
but did not enhance in TR-CEUS, which was proved to be
necrotic and carbonized tissue through histopathology. TR-
CEUS is a feasible tool to evaluate the transperineal laser-
ablated lesion in prostate operation and follow up.
It was found that the volume of the prostate gland
became enlarged immediately after TPLA, reached the peak
1 week later, and returned to the baseline level 1 month
later. The initial findings of this animal experiment were ana-
lyzed based on histopathological examinations. According to
the histopathological examinations carried out 1 day and 1
week after TPLA, the laser-ablated tissues became coagulated
and necrotic, and the tissues were clearly demarcated from
the surrounding normal tissues. There were bands of bleed-
ing and inflammatory responses between the laser-ablated
lesions and normal tissues. The findings of this study were
consistent with those in previous reports of laser ablation on
canine prostate [29] and other solid organs [30]. Previous
studies suggested that inflammatory reactions occurred after
thermal ablation, along with increased vascular permeability
in normal liver tissues and resulting leakage of the plasma,
platelets, and inflammatory cells into the interstitial tissues
[31]. Therefore, the increased volume of the prostate
observed after thermal ablation may be caused by these rea-
sons. In addition, the pathological findings of this study
revealed that the inflammatory cells not only appeared
around the laser-ablated sites but also in the normal prostate
tissues, which verified the fact that inflammatory cells leaked
through blood vessels. In previous reports, the prostate vol-
ume was closely related to acute urinary retention, lower
urinary tract symptoms, and bladder outlet obstruction from
[32–34]. The enlargement of the prostate volume could
cause urinary compression, resulting in the symptoms of
urinary retention. Based on the results of this study, the urin-
ary catheter should be placed and kept for at least 1 week
or longer after TPLA to avoid acute urinary retention.
The volume of laser-ablated lesions gradually increased in
the beagles’ prostate in the 1-month period. Previous litera-
ture reported that the volume of laser-ablated liver tumors
increased in a short period [20,21]. The heat-ablated lesions
can be considered as having three zones: the CZ, which is
located immediately beyond the application tip and under-
goes ablation-induced coagulative necrosis, the marginal
zone (MZ) of the sublethal hyperthermia, which is mostly
caused by the thermal conduction of the central area either
undergoing apoptosis or recovering from reversible injury,
and the untreated normal zone (UZ) of surrounding tissues
[35]. Chu et al. [36] elaborated that the heat-ablated lesions
are associated with direct cellular damages and indirect or
Figure 5. The pathological images of a beagle prostate were captured 1 month after TPLA (left 3w/600J, right 3w/1200J). (A) A prostate specimen with urinary
bladder and fluid aspirated from the cavity of the ablated lesion. A1. The liquid appeared yellowish and sticky on the glass slide. (A2) The HE staining image of the
liquid under high magnification (200 ) showed unstructured necrotic debris and inflammatory cells. (B) A cross-sectional view of the prostate gland with an
ablated lesion on each lobe. (B1) The HE staining image of the cavity wall showed necrotic tissues (#) and inflammatory cells () without a definite structure. (C)
The HE staining image of a prostate section under low magnification (10 ). C1. Inflammatory cells were seen on the wall of the cavity under high magnification
(200 ). C2. Inflammatory cells and normal prostate gland were seen in the MZ. C3. Normal prostate gland structures were seen in the NZ under high magnifica-
tion (200 ).
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delayed cellular damages. The direct cellular damages may
be immediate and caused by the hyperthermal conditions.
The definition of hyperthermal was to heat target tissue rap-
idly, to achieve ablative temperatures (> 55 C, but often >
80 C) in a few seconds. The indirect or delayed cellular dam-
ages after hyperthermal had been reported in a previous
study. Mehrdad Nikfarjam et al. reported that an increase in
tissue injury following laser ablation in mouse liver, with
finding that sublethal injury to the endothelium may lead to
alterations in blood flow and microvascular damage and
microthrombus formation, which participated in the progres-
sion of tissue injury [37]. Besides, the pro-inflammatory cyto-
kines that were released from the tissue of the MZ zone may
aggravate the indirect damage. The histopathological obser-
vation that many inflammatory cells were in the liquefaction
and cavity wall may support this hypothesis. These need fur-
ther study.
All laser-ablated lesions in the beagle prostate eventually
developed into a cystic cavity in this study. This phenom-
enon was observed in the canine prostate according to pre-
vious study [38]. Cowan et al. [39] believed that the canine
prostate contains a large amount of glandular tissues which
produce and store prostatic secretions, which is different
from human. The tissues undergo coagulative necrosis to
destroy the vascular system. Therefore, the necrotic materials
and the prostatic secretions cannot be transported and
absorbed in time. Ultimately, the ablated lesions develop
into the liquefaction cavity. However, this phenomenon was
also observed in clinical application. Madersbacher et al. [40]
discovered that intraprostatic cystic lesions were observed in
some patients from 6 to 12weeks after high-intensity
focused ultrasound, and 92% of patients underwent transient
urinary retention. Zvara et al. [41] demonstrated that the cav-
ity formed at 1 to 3weeks after intraprostatic absolute etha-
nol injection. A clinical trial of the management of BPH with
high-energy transurethral microwave therapy [22] showed
that intraprostatic cavities were found in 35 of 83 patients
(42%) and the presence of a cavity was positively correlated
positively with improvement in urinary performance and
relief of bladder outlet obstruction. The mean improvement
in peak urine flow rate in patients with a cavity was better
than in patients without a cavity at 3-month follow-up evalu-
ation (8.5 ± 7.3 vs 4.8 ± 5.4ml/s) [42]. So, the dynamic
changes after TPLA should be monitored closely. Once the
ablated lesions develop into liquefaction, the aspiration or
drainage should be performed as soon as possible to reduce
the pressure on the urethra and to reduce the inflammatory
response. One question that remains is whether or not anti-
inflammatory drugs can be used to reduce the inflammatory
response after TPLA. Dexamethasone was administered post-
operative to reduce edema according to the recent protocol
about TPLA in BPH [16]. This question needs to be verified in
the clinical application.
Several points can be learned from this study. Firstly, the
CEUS was able to measure the volume of TPLA for the
energy levels investigated in this study. The laser-ablated
lesions in prostate were demarcated from surrounding nor-
mal prostate tissue. Secondly, the changes in the prostate
volume after TPLA will provide a reference for determining
the duration of urinary catheterization. The transient enlarge-
ment of the prostate size could cause urinary compression,
resulting in the symptoms of acute urinary retention, which
prompts for clinical application that it should prolong appro-
priately the duration of urinary catheterization to avoid acute
urinary retention. Thirdly, this study showed that the volume
of laser-ablated lesions increased over time. The inflamma-
tory response may be involved in the process of laser
ablated lesion enlargement post-procedure, and possibly the
administration of anti-inflammatory drugs may reduce this
effect. However, the above assumptions have not been pro-
ven in patients, so further clinical trials should be car-
ried out.
There were some limitations to this study. The sample
size of the animals was small, and there was only one canine
used for the histopathological examinations done at 1 day
and 1 week after TPLA. Besides, the observation time in this
study was only up to 1 month, which was not long enough
to predict long-term changes.
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